The weekly litigation news digest is live. Subscribe now

IP Verse

Genmab competitive analysis

Loading summary...

Latest oppositions filed by Genmab

Explore patent oppositions filed by Genmab against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3656443
Use Of Trl Agonist And Anti-Cd47 Agent To Enhance Phagocytosis Of Cancer CellsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJun 29, 2022
EP3177645
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFERNov 17, 2021
EP3056514
Methods For Manipulating Phagocytosis Mediated By Cd47THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 17, 2020
EP3056515
Methods For Manipulating Phagocytosis Mediated By Cd47THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 17, 2020
EP2970493
Methods For Achieving Therapeutically Effective Doses Of Anti-Cd47 AgentsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 3, 2020
EP2647707
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHAJun 12, 2019

Latest patents of Genmab opposed by its competitors

Explore Genmab's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3319996
Jan 3, 2024Bispecific And Multispecific Antibodies And Method For Isolation Of Such2
EP2943507
Feb 26, 2020Inert Format3
EP3312196
Jul 17, 2019Antibodies Against Cd38 For Treatment Of Multiple Myeloma1
EP2535355
Jan 2, 2019Antibodies Against Cd38 For Treatment Of Multiple Myeloma1
EP2076769
Apr 25, 2018High Througput Methods For Characterization Of Antibodies1

Latest PTAB cases involving Genmab

Discover the latest PTAB cases involving Genmab, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Genmab with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GENMAB68 - -
MARGARET DIXON59 - - -
SECERNA11 - - -
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY - 37 - 3